Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment.
about
Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouseProfile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiencyBody composition in untreated adult patients with Laron syndrome (primary GH insensitivity)The GH/IGF-1 axis in ageing and longevityExpression of brain-derived neurotrophic factor, IGF-1 and cortisol elicited by regular aerobic exercise in adolescents.The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity.Lifetime congenital isolated GH deficiency does not protect from the development of diabetes.Different effects of IGF-I on insulin-stimulated glucose uptake in adipose tissue and skeletal muscle.Prevalence of hyperinsulinaemia among normozoospermic donors at Medfem Clinic, South Africa.Pharmacokinetics of IGF-1 in PAPP-A2-Deficient Patients, Growth Response, and Effects on Glucose and Bone Density.Mexican case report of a never-treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke.Primary growth hormone insensitivity and psychomotor delay.A 90-day safety study of genetically modified rice expressing rhIGF-1 protein in C57BL/6J rats.Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne.Serum insulin-like growth factor-I (IGF-I) levels during long-term IGF-I treatment of children and adults with primary GH resistance (Laron syndrome).Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver.Contribution of early glycemic status in the development of severe retinopathy of prematurity in a cohort of ELBW infants
P2860
Q24613998-9009B855-5191-4A34-994A-132FD3FCA250Q24654465-8BED742E-BE67-496F-9314-0C052DA93886Q28250001-E1AC59FE-659F-4A4B-8B07-11BEC7B56D82Q33817029-BC12BFDB-4810-4013-82A0-4F0EC475784FQ39597659-A22990EE-9855-42BD-BE5D-46AF61BDE1B1Q40364709-DE8EDFBE-5EDD-49A1-9ECD-376A07E8A55DQ41776005-EDD84E39-6E37-435D-83BE-C7EAF94E73A4Q42486135-5E68AEC7-1B6E-41E7-9BA8-E2C8D99100F6Q46595593-C9910DAF-2196-48EA-B1B5-7BE923CD25BCQ47656807-EE4519AC-68CF-40DA-9800-47B71F836508Q48275533-3DA332CD-5DA0-43FF-A3B9-DDFB4803D32FQ49432364-A9EDEA4B-6782-4EAB-AEB9-87F1FD9D37C1Q51414941-557CD7D7-0FC0-47AB-A3F3-356B5C61E7C2Q51534027-87AE8675-7C03-4687-93A7-A9B2DB950863Q51562510-692D90B2-BBD3-4933-8273-673706700695Q52313979-7F25EC86-DA5D-41C1-8CD4-497215221DA7Q58949190-8DE36EDC-9176-4353-9B00-D3B2D3D2BD3F
P2860
Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Carbohydrate metabolism in pri ...... ike growth factor-I treatment.
@en
type
label
Carbohydrate metabolism in pri ...... ike growth factor-I treatment.
@en
prefLabel
Carbohydrate metabolism in pri ...... ike growth factor-I treatment.
@en
P1433
P1476
Carbohydrate metabolism in pri ...... like growth factor-I treatment
@en
P2093
P304
P356
10.1016/0026-0495(95)90231-7
P433
10 Suppl 4
P577
1995-10-01T00:00:00Z